Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of ulipristal versus placebo for pre-operative treatment of symptomatic uterine myomas
2008-001804-22Phase 3Completed
- Sponsor
- PregLem
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Fibromyoma (LM) comparing Ulipristal + iron with Placebo + iron (2 arms). Primary endpoint: Primary efficacy endpoints. Started Jun 2008; status: completed.
02
Drugs
ulipristal
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on 2008-001804-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001804-22.